183 related articles for article (PubMed ID: 34291109)
21. Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum.
Serisier DJ; Carroll MP; Shute JK; Young SA
Respir Res; 2009 Jul; 10(1):63. PubMed ID: 19580650
[TBL] [Abstract][Full Text] [Related]
22. Association of Serum TGF-β1 Levels with Different Clinical Phenotypes of Cystic Fibrosis Exacerbation.
Sagwal S; Chauhan A; Kaur J; Prasad R; Singh M; Singh M
Lung; 2020 Apr; 198(2):377-383. PubMed ID: 31919585
[TBL] [Abstract][Full Text] [Related]
23. Reduced Smad3 protein expression and altered transforming growth factor-beta1-mediated signaling in cystic fibrosis epithelial cells.
Kelley TJ; Elmer HL; Corey DA
Am J Respir Cell Mol Biol; 2001 Dec; 25(6):732-8. PubMed ID: 11726399
[TBL] [Abstract][Full Text] [Related]
24. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
25. Molecular principles for heparin oligosaccharide-based inhibition of neutrophil elastase in cystic fibrosis.
Kummarapurugu AB; Afosah DK; Sankaranarayanan NV; Navaz Gangji R; Zheng S; Kennedy T; Rubin BK; Voynow JA; Desai UR
J Biol Chem; 2018 Aug; 293(32):12480-12490. PubMed ID: 29903912
[TBL] [Abstract][Full Text] [Related]
26. Antibody response against Pseudomonas aeruginosa and its relationship with immune mediators in the upper and lower airways of cystic fibrosis patients.
Mauch RM; Hentschel J; Aanaes K; Barucha A; Nolasco da Silva MT; Levy CE; Høiby N; Mainz JG
Pediatr Pulmonol; 2020 Apr; 55(4):959-967. PubMed ID: 32022432
[TBL] [Abstract][Full Text] [Related]
27. Pseudomonas aeruginosa infection, but not mono or dual-combination CFTR modulator therapy affects circulating regulatory T cells in an adult population with cystic fibrosis.
Westhölter D; Beckert H; Straßburg S; Welsner M; Sutharsan S; Taube C; Reuter S
J Cyst Fibros; 2021 Nov; 20(6):1072-1079. PubMed ID: 34030985
[TBL] [Abstract][Full Text] [Related]
28. Effects of cystic fibrosis transmembrane conductance regulator and DeltaF508CFTR on inflammatory response, ER stress, and Ca2+ of airway epithelia.
Hybiske K; Fu Z; Schwarzer C; Tseng J; Do J; Huang N; Machen TE
Am J Physiol Lung Cell Mol Physiol; 2007 Nov; 293(5):L1250-60. PubMed ID: 17827250
[TBL] [Abstract][Full Text] [Related]
29. Sputum neutrophil elastase and its relation to pediatric bronchiectasis severity: A cross-sectional study.
Ali HA; Fouda EM; Salem MA; Abdelwahad MA; Radwan HH
Health Sci Rep; 2022 May; 5(3):e581. PubMed ID: 35509417
[TBL] [Abstract][Full Text] [Related]
30. Digitoxin for Airway Inflammation in Cystic Fibrosis: Preliminary Assessment of Safety, Pharmacokinetics, and Dose Finding.
Zeitlin PL; Diener-West M; Callahan KA; Lee S; Talbot CC; Pollard B; Boyle MP; Lechtzin N
Ann Am Thorac Soc; 2017 Feb; 14(2):220-229. PubMed ID: 28006108
[TBL] [Abstract][Full Text] [Related]
31. Effects of cystic fibrosis airway secretions on rat lung: role of neutrophil elastase.
Rees DD; Brain JD
Am J Physiol; 1995 Aug; 269(2 Pt 1):L195-202. PubMed ID: 7653580
[TBL] [Abstract][Full Text] [Related]
32. Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation.
Harris JK; Wagner BD; Zemanick ET; Robertson CE; Stevens MJ; Heltshe SL; Rowe SM; Sagel SD
Ann Am Thorac Soc; 2020 Feb; 17(2):212-220. PubMed ID: 31604026
[No Abstract] [Full Text] [Related]
33. Use of low field nuclear magnetic resonance to monitor lung inflammation and the amount of pathological components in the sputum of cystic fibrosis patients.
Abrami M; Maschio M; Conese M; Confalonieri M; Di Gioia S; Gerin F; Dapas B; Tonon F; Farra R; Murano E; Zanella G; Salton F; Torelli L; Grassi G; Grassi M
Magn Reson Med; 2020 Jul; 84(1):427-436. PubMed ID: 31788856
[TBL] [Abstract][Full Text] [Related]
34. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.
Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK
Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078
[TBL] [Abstract][Full Text] [Related]
35. Cytokines and inflammatory mediators do not indicate acute infection in cystic fibrosis.
Wolter JM; Rodwell RL; Bowler SD; McCormack JG
Clin Diagn Lab Immunol; 1999 Mar; 6(2):260-5. PubMed ID: 10066664
[TBL] [Abstract][Full Text] [Related]
36. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
Sagel SD; Kapsner RK; Osberg I
Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
[TBL] [Abstract][Full Text] [Related]
37. Tgf-β1 inhibits Cftr biogenesis and prevents functional rescue of ΔF508-Cftr in primary differentiated human bronchial epithelial cells.
Snodgrass SM; Cihil KM; Cornuet PK; Myerburg MM; Swiatecka-Urban A
PLoS One; 2013; 8(5):e63167. PubMed ID: 23671668
[TBL] [Abstract][Full Text] [Related]
38. Differential regulation of inflammation by inflammatory mediators in cystic fibrosis lung epithelial cells.
Tsuchiya M; Kumar P; Bhattacharyya S; Chattoraj S; Srivastava M; Pollard HB; Biswas R
J Interferon Cytokine Res; 2013 Mar; 33(3):121-9. PubMed ID: 23289731
[TBL] [Abstract][Full Text] [Related]
39. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.
Zemanick ET; Harris JK; Wagner BD; Robertson CE; Sagel SD; Stevens MJ; Accurso FJ; Laguna TA
PLoS One; 2013; 8(4):e62917. PubMed ID: 23646159
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory and immunological biomarkers are not related to survival in adults with Cystic Fibrosis.
Moffitt KL; Martin SL; Jones AM; Webb AK; Cardwell C; Tunney MM; Elborn JS
J Cyst Fibros; 2014 Jan; 13(1):63-8. PubMed ID: 23860440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
